The risk of statin-induced myopathy is raised by a common genetic variation of the organic anion-transporting polypeptide 1B1 (OATP 1B1), which is encoded by the gene SLCO1B1. This protein is a member of the solute carrier organic anion transporter family. Here, SLCO1B1 is linked to myopathy.